Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Sodium benzoate by SyneuRx International (Taiwan) for Schizophrenia: Likelihood of Approval
Sodium benzoate is under clinical development by SyneuRx International (Taiwan) and currently in Phase III for Schizophrenia. According to GlobalData,...